Sartorius Stedim Biotech SA
OTC:SRTOY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sartorius Stedim Biotech SA
OTC:SRTOY
|
FR |
|
A
|
Alamos Gold Inc
F:1AL
|
CA |
|
A
|
AnaptysBio Inc
F:AN6
|
US |
|
C
|
Coface SA
SWB:65C
|
FR |
|
L
|
Lagardere SA
DUS:LAG
|
FR |
|
Almirall SA
OTC:ALMRY
|
ES |
|
C
|
CarGurus Inc
F:0C6
|
US |
|
N
|
New Century Resources Corp
OTC:NCRE
|
CY |
|
Schneider Electric SE
F:SNDB
|
FR |
|
Red Sky Energy Ltd
ASX:ROG
|
AU |
|
A
|
Asahi Kasei Corp
SWB:ASAA
|
JP |
|
J
|
Jones Lang LaSalle Inc
LSE:0JPB
|
US |
|
Seadrill Ltd
F:P4F
|
BM |
|
M
|
Mitsubishi Chemical Group Corp
DUS:M3C
|
JP |
|
C
|
Citigroup Inc
LSE:0R01
|
US |
|
Saipem SpA
F:SPE1
|
IT |
Wall St Price Targets
SRTOY Price Targets Summary
Sartorius Stedim Biotech SA
According to Wall Street analysts, the average 1-year price target for SRTOY is 27.61 USD with a low forecast of 24.8 USD and a high forecast of 32.16 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SRTOY's stock price target?
Price Target
27.61
USD
According to Wall Street analysts, the average 1-year price target for SRTOY is 27.61 USD with a low forecast of 24.8 USD and a high forecast of 32.16 USD.
What is the Revenue forecast for Sartorius Stedim Biotech SA?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 8 years is 12%.
What is the Operating Income forecast for Sartorius Stedim Biotech SA?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 8 years is 17%.
What is the Net Income forecast for Sartorius Stedim Biotech SA?
Projected CAGR
23%
Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 8 years is 23%.
